Sign in

CIK 0001855175

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
271467257
Phone
+1 858-333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$41,142
in 1 filing, $41K under 10b5-1 plans

Net −$41,142. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Stengone Carmine N. −$41K CEO and President sold 13% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-08 Stengone Carmine N. CEO and President Option exercise 10b5-1 +2,500 $1.01 $3K 19,717
2026-09-08 Stengone Carmine N. CEO and President Sale 10b5-1 −2,500 $16.46 $41K 17,217
2026-09-08 Stengone Carmine N. CEO and President Option exercise · Stock Option (right to buy) 10b5-1 −2,500 274,430
2026-08-03 Stengone Carmine N. CEO and President Option exercise 10b5-1 +2,500 $1.01 $3K 19,717
2026-08-03 Stengone Carmine N. CEO and President Sale 10b5-1 −2,500 $16.01 $40K 17,217
2026-08-03 Stengone Carmine N. CEO and President Option exercise · Stock Option (right to buy) 10b5-1 −2,500 276,930
2026-07-09 Lorrain Daniel S. Chief Scientific Officer Option exercise 10b5-1 +25 $1.01 $25 135,227
2026-07-09 Lorrain Daniel S. Chief Scientific Officer Sale 10b5-1 −25 $16.00 $400 135,202
2026-07-09 Lorrain Daniel S. Chief Scientific Officer Option exercise · Stock Option (right to buy) 10b5-1 −25 33,257
2026-07-08 Lorrain Daniel S. Chief Scientific Officer Option exercise 10b5-1 +1,015 $1.01 $1K 136,217
2026-07-08 Lorrain Daniel S. Chief Scientific Officer Sale 10b5-1 −1,015 $16.00 $16K 135,202
2026-07-08 Lorrain Daniel S. Chief Scientific Officer Option exercise · Stock Option (right to buy) 10b5-1 −1,015 33,282
2026-07-08 Stengone Carmine N. CEO and President Option exercise 10b5-1 +2,500 $1.01 $3K 19,717
2026-07-08 Stengone Carmine N. CEO and President Sale 10b5-1 −2,500 $16.00 $40K 17,217
2026-07-08 Stengone Carmine N. CEO and President Option exercise · Stock Option (right to buy) 10b5-1 −2,500 279,430
2026-07-01 Lorrain Daniel S. Chief Scientific Officer Option exercise 10b5-1 +4,183 $1.01 $4K 143,555
2026-07-01 Lorrain Daniel S. Chief Scientific Officer Sale 10b5-1 −5,852 $15.67 $92K 137,703
2026-07-01 Lorrain Daniel S. Chief Scientific Officer Sale 10b5-1 −2,501 $16.24 $41K 135,202
2026-07-01 Lorrain Daniel S. Chief Scientific Officer Option exercise · Stock Option (right to buy) 10b5-1 −4,183 34,297
2026-06-30 Lorrain Daniel S. Chief Scientific Officer Option exercise 10b5-1 +28,826 $1.01 $29K 168,198

Page 1 of 7 · 139 trades